Schmid MP, Harrabi S, Herfarth K, Bruland ØS, Welzel T, Haberer T, Ellerbrock M, Debus J, Uhl M, Seidensaal K(2022) Particle Therapy in Adult Patients with Pelvic Ewing Sarcoma-Tumor and Treatment Characteristics and Early Clinical Outcomes Cancers (Basel), 14(24) DOI 10.3390/cancers14246045, PubMed 36551530
Tornes AJK, Stenberg VY, Larsen RH, Bruland ØS, Revheim ME, Juzeniene A(2022) Targeted alpha therapy with the 224Ra/212Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma Front Med (Lausanne), 9, 1058863 DOI 10.3389/fmed.2022.1058863, PubMed 36507500
Stacchiotti S, Dürr HR, Schaefer IM, Woertler K, Haas R, Trama A, Caraceni A, Bajpai J, Baldi GG, Bernthal N, Blay JY, Boye K, Broto JM, Chen WT, Dei Tos PA, Desai J, Emhofer S, Eriksson M, Gronchi A, Gelderblom H, Hardes J, Hartmann W, Healey J, Italiano A, Jones RLet al.(2022) Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts Cancer Treat Rev, 112, 102491 DOI 10.1016/j.ctrv.2022.102491, PubMed 36502615
